Industry
Roche Recognizes med fusion as a Molecular Center of Excellence
Roche Diagnostics, a biotech company focused on research-based healthcare, has formed an alliance with med fusion LLC, an integrated laboratory and clinical trials service organization, designating the company as a Roche Molecular Center of Excellence for the next five years. More...06 Jun 2012
Ventana Signs Agreement to Commercialize Antibody Associated with Cancer Diagnostics
Ventana Medical Systems, Inc. has signed an exclusive license agreement with the German Cancer Research Center and University Hospital Heidelberg to commercialize an immunohistochemistry primary antibody that detects a mutated protein found in cancer patients.
More...01 Jun 2012
Ventana Acquires In Vitro Rights for ERG Protein Measurement
Ventana Medical Systems, Inc., a member of the Roche Group, announced it has co-exclusively sublicensed patents from Gen-Probe Incorporated, giving the company in vitro diagnostic rights for measuring ETS Related Gene protein expression through immunohistochemistry in prostate tissue. More...24 May 2012
Myriad and Intermountain Healthcare to Collaborate on Molecular Diagnostics
Myriad Genetics, Inc., a molecular diagnostics company, and Intermountain Healthcare, a nonprofit organization that provides affordable medical care, have signed a collaborative research agreement to study molecular diagnostic tests developed by Myriad. More...24 May 2012
4-Antibody and Evotec Collaborate on Early Antibody Functionality Testing
4-Antibody and Evotec have formed a strategic collaboration to launch a new high-content screening platform for early antibody functionality testing, agreeing to share financial rewards of the collaboration. More...23 May 2012
Affymetrix and ScreenCell Sign Distribution Agreement for Tumor Cell Technology
Affymetrix, Inc. and ScreenCell, have announced the signing of a worldwide distribution agreement for ScreenCell’s isolation devices and dilution buffers, which collect Circulating Tumor Cells in peripheral blood. More...18 May 2012
Agilent Technologies Acquires Dako to Expand Diagnostic Solutions Portfolio
Agilent Technologies Inc., a bio-analytical technology solutions company, has announced an agreement to acquire Dako, a global, tissue-based cancer diagnostic company, from the private equity group EQT for USD 2.2 billion. More...18 May 2012
Gold Member
Collection and Transport System
PurSafe Plus®
8-Channel Pipette
SAPPHIRE 20–300 µL
Sample Transportation System
Tempus1800 Necto
In Other News
Qiagen Expands Portfolio with AmniSure Acquisition
Sony Invests Millions in Medical Devices and Clinical Pathology
Hologic Set to Acquire Gen-Probe
Collaboration and Licensing Agreement Expanded to Exploit Isoforms as Diagnostic Markers
Beckman Coulter Life Sciences Acquires Blue Ocean Biomedical
Sysmex and Roche Extend Hematology Alliance
Success in Medical Technology Is Predictable
Personalized Diagnostics Is Dynamic Area of IVD Sector
Collaboration Develops Companion Diagnostic Test for Cancer Therapy
BD Diagnostics Acquires Kiestra and Expands Microbiology Portfolio
Cancer Testing Market to Experience Better Than Average Growth
Current Opportunity and Future Potential of Personalized Medicine
Rubicon Genomics Enters Cancer Diagnostics Agreement with Agendia
OGT Enters Licensing Agreement for Twelve Colorectal Cancer Biomarkers
Analytica 2012 Live Lab Takes Visitors into the World of Laboratories
Signal Genetics Expands Oncology Pipeline with Acquisition of ChipDX
Rusnano and Magnisense to Collaborate on Advanced Diagnostic Systems
Life Technologies and DaAn Gene Form Joint Diagnostic Business
Waters and Tecan Sign Agreement for Clinical Assay Platform
Ventana and Bayer to Collaborate on Companion Diagnostic
Gen-Probe Acquires GTI Diagnostics for USD 53 Million
Qiagen and Max Planck to Develop TB Molecular Diagnostic
Ventana and Syndax to Develop Companion Diagnostic
LabMedica Industry News channel reports on mergers and takeovers, on cooperative agreements and on trends in the IVD industry worldwide.